Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788346 | SCV000927418 | uncertain significance | not provided | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258966 | SCV003948162 | uncertain significance | Inborn genetic diseases | 2023-05-17 | criteria provided, single submitter | clinical testing | The c.2147G>A (p.R716Q) alteration is located in exon 11 (coding exon 11) of the CR2 gene. This alteration results from a G to A substitution at nucleotide position 2147, causing the arginine (R) at amino acid position 716 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003453627 | SCV004180436 | uncertain significance | Immunodeficiency, common variable, 7 | 2023-04-11 | criteria provided, single submitter | clinical testing |